SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) reported 2 transactions at VISTAGEN THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/3/2021ACC: 0001415889-21-004226
DirectorOfficer· PRES./CHIEF SCIENTIFIC OFFICER
Since Aug 2018
+371.00
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.11K acquired · 740.00 disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−740.00
Price / share
—
Trade value
—
% of position
2.1%
8/23/2021
34.64K→33.90K
Common Stock
Direct
Shares
+1.11K
Price / share
—
Trade value
—
% of position
1.8%
9/2/2021
60.22K→61.34K
Total
Net shares
+371.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/23/2021 | G · Gift | −740.00 | — | — | 2.1% | 34.64K | 33.90K |
| Common Stock Direct | 9/2/2021 | G · Gift | +1.11K | — | — | 1.8% | 60.22K | 61.34K |
| Total | +371.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported